SCHEMBL21973749

SCHEMBL21973749

c1ccc(-c2cc(-c3ccccc3)cc(-c3nc(-c4ccccc4)cc(-c4cc(-c5cc(-c6ccccc6)nc(-c6cc(-c7ccccc7)cc(-c7ccccc7)c6)n5)cc(-n5c6ccccc6c6ccccc65)c4)n3)c2)cc1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 4/20 0.44
▸ L3MBTL1 Q9Y468 3/20 0.44
▸ ATM Q13315 2/20 0.44
▸ MEN1 O00255 7/20 0.41
▸ KMT2A Q03164 7/20 0.41
▸ HPGD P15428 5/20 0.41
▸ MAPT P10636 5/20 0.41
▸ ALDH1A1 P00352 4/20 0.41
▸ NTSR1 P30989 1/20 0.41
▸ LMNA P02545 2/20 0.40
▸ ADORA2A P29274 2/20 0.39
▸ ADORA1 P30542 2/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ ACHE P22303 1/20 0.37
▸ GLA P06280 1/20 0.37
▸ DHODH Q02127 1/20 0.36
▸ AGTR1 P30556 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21973894 0.99 MEN1 (0.44) KDM4EL3MBTL1ATMMEN1KMT2A
SCHEMBL21973744 0.97 MEN1 (0.45) KDM4EL3MBTL1ATMMEN1KMT2A
SCHEMBL24727913 0.96 MEN1 (0.47) KDM4EL3MBTL1ATMMEN1KMT2A
SCHEMBL8400293 0.96 MEN1 (0.47) KDM4EL3MBTL1ATMMEN1KMT2A
SCHEMBL14425787 0.94 MEN1 (0.46) KDM4EL3MBTL1ATMMEN1KMT2A
SCHEMBL21973747 0.94 MEN1 (0.49) KDM4EL3MBTL1ATMMEN1KMT2A
SCHEMBL14425762 0.94 MEN1 (0.49) KDM4EL3MBTL1ATMMEN1KMT2A
SCHEMBL14425739 0.94 MEN1 (0.49) KDM4EL3MBTL1ATMMEN1KMT2A
SCHEMBL9881139 0.94 MEN1 (0.45) KDM4EL3MBTL1ATMMEN1KMT2A
SCHEMBL13233263 0.94 KDM4E (0.47) KDM4EL3MBTL1ATMMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200140416-A1 COMPOUND, OLED DISPLAY PANEL AND ELECTRONIC DEVICE WUHAN TIANMA MICRO-ELECTRONICS CO., LTD. (CN) 2020-05-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200140416-A1 COMPOUND, OLED DISPLAY PANEL AND ELECTRONIC DEVICE OCIAD2, OCIAD1, EED KDM4E 2113/4885L3MBTL1 2864/4885ATM 3949/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback